Cargando…
Statins in COVID-19 Therapy
Inhibitors of 3-hydroxy-3methylgultaryl-coenzyme A reductase (statins) are one of the main groups of drugs used in preventing and treating cardiovascular diseases worldwide. They are widely available, cheap, and well-tolerated. Based on statins’ pleiotropic properties, including improvement of endot...
Autores principales: | Olszewska-Parasiewicz, Justyna, Szarpak, Łukasz, Rogula, Sylwester, Gąsecka, Aleksandra, Szymańska, Urszula, Kwiatkowska, Maria, Jaguszewski, Milosz J., Sierpiński, Radosław, Zaczyński, Artur, Wierzba, Waldemar, Kosior, Dariusz A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234902/ https://www.ncbi.nlm.nih.gov/pubmed/34208435 http://dx.doi.org/10.3390/life11060565 |
Ejemplares similares
-
Inclisiran—Silencing the Cholesterol, Speaking up the Prognosis
por: Rogula, Sylwester, et al.
Publicado: (2021) -
LDL-Cholesterol and Platelets: Insights into Their Interactions in Atherosclerosis
por: Gąsecka, Aleksandra, et al.
Publicado: (2021) -
Efficacy and safety of levosimendan and dobutamine in heart failure: A systematic review and meta-analysis
por: Jaguszewski, Milosz J., et al.
Publicado: (2021) -
Impact of diabetes mellitus on in-hospital mortality in adult patients with COVID-19: a systematic review and meta-analysis
por: Kaminska, Halla, et al.
Publicado: (2021) -
Biomarker-based approach to determine etiology and severity of pulmonary hypertension: Focus on microRNA
por: Rogula, Sylwester, et al.
Publicado: (2022)